13F HOLDINGS REPORT
Foresite Capital Management IV, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-013923
Total Value
$108.8M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Pharvaris N.V. | PHVS | 4,397,881 | $84.3M | 77.49% |
| 2 | Kura Oncology, Inc. | KURA | 1,726,882 | $15.0M | 13.83% |
| 3 | Lyell Immunopharma, Inc. | LYEL | 8,325,000 | $5.3M | 4.90% |
| 4 | Relay Therapeutics Inc. | RLAY | 1,000,000 | $4.1M | 3.79% |